# Home Test for Measuring Plasma P-tau217 in Alzheimer's Disease

> **NCT06622135** · NA · TERMINATED · sponsor: **Insight Research Institute** · enrollment: 16 (actual)

## Conditions studied

- Alzheimer Disease
- Healthy Subjects

## Interventions

- **DEVICE:** Tasso Lancet Device

## Key facts

- **NCT ID:** NCT06622135
- **Lead sponsor:** Insight Research Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2024-09-19
- **Primary completion:** 2024-12-07
- **Final completion:** 2024-12-07
- **Target enrollment:** 16 (ACTUAL)
- **Why stopped:** Lack of Funding
- **Last updated:** 2025-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06622135

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06622135, "Home Test for Measuring Plasma P-tau217 in Alzheimer's Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06622135. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*